Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Capital Employed (2018 - 2025)

Historic Return on Capital Employed for Arcus Biosciences (RCUS) over the last 8 years, with Q3 2025 value amounting to 0.47%.

  • Arcus Biosciences' Return on Capital Employed fell 1700.0% to 0.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.47%, marking a year-over-year decrease of 1700.0%. This contributed to the annual value of 0.37% for FY2024, which is 300.0% down from last year.
  • Per Arcus Biosciences' latest filing, its Return on Capital Employed stood at 0.47% for Q3 2025, which was down 1700.0% from 0.37% recorded in Q2 2025.
  • In the past 5 years, Arcus Biosciences' Return on Capital Employed registered a high of 0.06% during Q3 2022, and its lowest value of 0.47% during Q3 2025.
  • Its 5-year average for Return on Capital Employed is 0.24%, with a median of 0.28% in 2024.
  • In the last 5 years, Arcus Biosciences' Return on Capital Employed soared by 4400bps in 2022 and then tumbled by -3800bps in 2023.
  • Over the past 5 years, Arcus Biosciences' Return on Capital Employed (Quarter) stood at 0.05% in 2021, then tumbled by -572bps to 0.24% in 2022, then plummeted by -46bps to 0.35% in 2023, then grew by 7bps to 0.33% in 2024, then crashed by -44bps to 0.47% in 2025.
  • Its Return on Capital Employed was 0.47% in Q3 2025, compared to 0.37% in Q2 2025 and 0.45% in Q1 2025.